Rhodei-litorin [6766]
Rhodei-litorin
| SMILES | CSCCC(NC(=O)C(Cc1ccccc1)NC(=O)C(Cc1c[nH]cn1)NC(=O)CNC(=O)C(NC(=O)C(C)NC(=O)C(Cc1c[nH]c2ccccc12)NC(=O)C(CC(C)C)NC(=O)C(N)CCC(N)=O)C(C)O)C(=O)O |
| InChIKey | SVUYIHOQEOWECO-UHFFFAOYSA-N |
| Sequence | QLWATGHFM |
| HELM | PEPTIDE1{[*C(=O)C1CCC(=O)N1 |$_R2;;;;;;;;$|].[*C(=O)C(C(C)CC)N* |$_R2;;;;;;;;;_R1$|].(W,[dW]).(A,[dA]).[*C(=O)C(C(C)O)N* |$_R2;;;;;;;;_R1$|].G.(H,[dH]).(F,[dF]).(M,[dM]).[am]}$$$$V2.0 |
Chemical Properties
| Hydrogen bond acceptors | None |
| Hydrogen bond donors | None |
| Rotatable bonds | None |
| Log P | None |
| Molecular weight (Da) | None |
Database connections
|
|
No bioactivity data available.
Rhodei-litorin
Drug properties
| Molecular type | Peptide |
| Physiological/Surrogate | Surrogate |
| Approved drug | No |
Distribution across phases (no. indications)
Phase I
0
Phase II
0
Phase III
0
Phase IV
0
Database connections
|
|